	Outcomes and safety of minimally invasive surgery in gallbladder cancer: international, multicenter cohort study. Int J Surg Law JH, Raptis D, Leong EKF, Tan CQ, Koh SJQ, Bayramov N, Belli A, Ferrero A, Chong CNC, Libia A, Lopez-Lopez V, Conticchio M, Machairas N, Rotellar F, Kow AWC, ISLS study group. PMID: 41403280 [PubMed - as supplied by publisher]
	Macrophage Polarization in the Tumor Microenvironment of Hepatocellular Carcinoma: From Mechanistic Insights to Translational Therapies. Cancer Control Fu X, Pang M, Wang Z, Wang H. PMID: 41403016 [PubMed - indexed for MEDLINE]
	Familial risk of pancreatic cancer and interaction with hyperglycemia, smoking, and obesity among first-degree relatives. BMC Cancer Kim HJ, Kang TU, Swan H, Park SM. PMID: 41402815 [PubMed - as supplied by publisher]
	Analysis of risk factors for early mortality following hepatectomy in hepatocellular carcinoma patients. BMC Surg Kou C, Zhu H, Fan L, Fan W, Cheung TT, Ji R. PMID: 41402783 [PubMed - indexed for MEDLINE]
	Explainable machine learning model for predicting early recurrence and distant metastasis after surgery in early-onset colorectal cancer. Surgery Ni W, Zhang B, Gao Y, Jiang J, Ye Y, Chen J, Lin X, Yu H, Wang L, Xiao C. PMID: 41402185 [PubMed - as supplied by publisher]
	American Cancer Society's Report on the Status of Cancer Disparities in the United States, 2025. CA Cancer J Clin Islami F, Arias G, Lee D, Wiese D, Baeker Bispo J, Yabroff KR, Siegel RL, Bandi P, Nargis N, Patel AV, Thienprayoon PP, Kamal AH, Daniels EC, Annunziata CM, Sloan K, Lacasse LA, Winn RA, Brawley OW, Guerra CE, Dahut WL, Jemal A. PMID: 41400551 [PubMed - indexed for MEDLINE]
	A retrospective cohort study on short-term outcomes after oesophagectomy for cancer in Japan. Br J Surg Makino T, Endo H, Yamamoto H, Hasegawa H, Yamasaki M, Yasuda T, Ueno H, Shirabe K, Kimura Y, Takeuchi H, Eguchi H, Doki Y. PMID: 41400037 [PubMed - in process]
	IL-6/GP130/JAK/STAT3 Pathway Activation in Pancreatic Ductal Adenocarcinoma and Its Association With Clinical Features: Protocol for a Retrospective Cross-Sectional Study. JMIR Res Protoc Mellenthin C, Schaller F, Vignot L, Peisl S, Vesce R, Esposito I, Gonelle-Gispert C, Schneider C, Adamina M, Bühler LH. PMID: 41397158 [PubMed - indexed for MEDLINE]
	Liposomal nanomedicine in Cancer therapy: advances in drug delivery. Expert Rev Anticancer Ther Zaragoza-Jiménez A, López-Lara LF, Álvarez-Velázquez ED, Aceves-Enríquez RS, Muñoz-Valle JF, Hernandez-Bello J, Salinas-Santander MA, Vallejo-Cardona AA, Rios-Ibarra CP. PMID: 41396166 [PubMed - as supplied by publisher]
	Adoption of multi-slice spiral computed tomography and multiparametric magnetic resonance imaging in the differential diagnosis of pancreatic cancer and chronic pancreatitis. Am J Cancer Res Ao L, Meng L, Liu W, Chen Y. PMID: 41395299 [PubMed]
	OTU deubiquitinases in cancer pathogenesis and precision therapy. Am J Cancer Res Yu S, Wang Z, Wang M, Li K, Shang X, Zhao Y, Hu R, Li H, Su M. PMID: 41395287 [PubMed]
	The molecular logic of early metastasis in pancreatic cancer: crosstalk between tumor and microenvironment. Front Cell Dev Biol Costamagna A, Ghiglione N, Martini M. PMID: 41394398 [PubMed]
	Preclinical evaluation of uPAR-ICG-FVIOs for dual-mode imaging and magnetic hyperthermia therapy in pancreatic cancer. Front Pharmacol Luo T, Zhang K, Wu C, Wu X, Yang H, Chen Z, Jiang F. PMID: 41394152 [PubMed]
	Nonbacterial Thrombotic Endocarditis (Libman-Sacks) as a Complication of Metastatic Pancreatic Cancer: A Case Report of Diagnostic and Therapeutic Challenges. Cureus Sultan W, Shibli M, Madhu V, Wilson M, Burmeister J. PMID: 41393736 [PubMed]
	Systemic and local decorin levels mirror the clinical course of pancreatic cancer. J Pathol Clin Res Svensson M, Lehn S, Jacobsen H, Olsson Hau S, Jönsson G, Pietras K, Jirström K. PMID: 41392017 [PubMed - indexed for MEDLINE]
	Contrast-enhanced harmonic endoscopic ultrasonography (EUS)-guided tissue acquisition significantly improves diagnostic yield for small liver metastases derived from pancreatic cancer: a prospective study. Pancreatology Emori T, Itonaga M, Ashida R, Nakahata A, Tamura T, Kawaji Y, Tamura T, Yamashita Y, Fukatsu K, Shimokawa T, Kitano M. PMID: 41392004 [PubMed - as supplied by publisher]
	Emerging nanoparticle-based therapies for pancreatic cancer: Current clinical landscape. Adv Drug Deliv Rev Salgado A, Zalba S, Lasarte JJ, Garrido MJ. PMID: 41391820 [PubMed - as supplied by publisher]
	ASO Visual Abstract: Neoadjuvant Treatment is a Risk Factor for Clinically Relevant Chyle Leak (ISGPS Grade B/C) after Pancreatic Cancer Resection: A Retrospective Cohort Study. Ann Surg Oncol Leonhardt CS, Shraim S, Abdelazim K, Hinz U, Polychronidis G, Hank T, Schneider M, Hackert T, Strobel O, Loos M, Buechler MW, Al-Saeedi M. PMID: 41390552 [PubMed - as supplied by publisher]
	BAG6 promotes hepatocellular carcinoma growth via enhancing PLK1-mediated aerobic glycolysis. Int J Biol Macromol Zhang W, Du D, Lu H, Zhang W, Lei J. PMID: 41390024 [PubMed - as supplied by publisher]
	Treatment landscape from first- to third-line therapy and quality of life data of patients with pancreatic cancer from the prospective German PARAGON (Platform for Outcome, Quality of Life, and Translational Research on Pancreatic Cancer) registry (IKF-PARAGON study). Int J Cancer Goetze TO, Al-Batran SE, Liersch R, Scheuer L, Goehler T, Kaiser U, Denzlinger C, Brandl S, Pink D, Uhlig J, Maasberg M, Loose M, Schaaf M, Sookthai D, Zäpf B, Pauligk C, Habibzade T, Hofheinz RD, Koch C, AIO Study Group. PMID: 41388765 [PubMed - as supplied by publisher]

Articles 1 - 20 / 58496

Page 1 of 2925



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy